Condition 1: Obesity. Condition 2: cardiovascular disorders. Overweight and obesity Encounter for screening for cardiovascular disorders
Conditions
Interventions
Intervention 1: First intervention group: Obesity
According to the crossover design, each subject will participate in 4 experimental sessions: 2 sessions in the morning and 2 sessions in the evening following caffeine (3 mg/kg) or placebo intake. Eac
Sponsors
INTERNATIONAL SCIENCE AND TECHNOLOGY UNIVERSITY
Eligibility
Sex/Gender
Male
Age
20 Years to 30 Years
Inclusion criteria
Inclusion criteria: Don't smoke. Do not consume alcohol. Have not taken any sports supplements in the past 6 months. Do not have a habit of consuming caffeine. Do not suffer from cardiovascular and hematological diseases. Healthy subjects should have a body mass index of 18.5 - 24.9. Obese subjects should have a body mass index = 30. Trained subjects should have a regular exercise history in the past 3 years. Untrained subjects should not have a history of regular exercise in the past 6 months.
Exclusion criteria
Exclusion criteria: Having caffeine habituation Cardiovascular and hematological diseases Having a physical injury that prevents from exercising. Having a body mass index of less than 18.5 and more than 24.9 for healthy subjects and less than 30 for obese subjects
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Von Willebrand factor level. Timepoint: Before, immediately after, and 30 minutes after each exercise session. Method of measurement: ELISA.;VIII factor level. Timepoint: Before, immediately after, and 30 minutes after each exercise session. Method of measurement: ELISA.;Fibrinogen level. Timepoint: Before, immediately after, and 30 minutes after each exercise session. Method of measurement: Coagulometer.;Platelet count. Timepoint: Before, immediately after, and 30 minutes after each exercise session. Method of measurement: Blood cell counter.;Inhibitor of plasminogen activator type 1 (PAI-1) activity. Timepoint: Before, immediately after, and 30 minutes after each exercise session. Method of measurement: ELISA.;Tissue plasminogen activator (tPA) antigen level. Timepoint: Before, immediately after, and 30 minutes after each exercise session. Method of measurement: ELISA.;TPA activity. Timepoint: Before, immediately after, and 30 minutes after each exercise session. Method of measurement: ELISA.;Testosterone level. Timepoint: Before, immediately after, and 30 minutes after each exercise session. Method of measurement: ELISA.;Cortisol level. Timepoint: Before, immediately after, and 30 minutes after each exercise session. Method of measurement: ELISA.;Anaerobic power. Timepoint: At the end of each exercise session. Method of measurement: Wingate test. | — |
Countries
Turkey
Contacts
Public ContactDavar Khodadadi
Islamic Azad University
Outcome results
None listed